Privia Health Group, Inc. (NASDAQ:PRVA) Shares Sold by State of Alaska Department of Revenue

State of Alaska Department of Revenue reduced its stake in Privia Health Group, Inc. (NASDAQ:PRVAFree Report) by 1.0% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 62,542 shares of the company’s stock after selling 649 shares during the period. State of Alaska Department of Revenue owned approximately 0.05% of Privia Health Group worth $1,225,000 at the end of the most recent reporting period.

Several other large investors have also recently added to or reduced their stakes in the stock. Park Place Capital Corp boosted its position in shares of Privia Health Group by 115.4% in the first quarter. Park Place Capital Corp now owns 2,492 shares of the company’s stock worth $49,000 after buying an additional 1,335 shares during the period. Benjamin Edwards Inc. lifted its position in Privia Health Group by 44.9% during the 4th quarter. Benjamin Edwards Inc. now owns 3,239 shares of the company’s stock worth $75,000 after acquiring an additional 1,003 shares in the last quarter. Benjamin F. Edwards & Company Inc. acquired a new position in Privia Health Group during the 4th quarter worth approximately $158,000. International Assets Investment Management LLC boosted its holdings in Privia Health Group by 2,721.7% in the 4th quarter. International Assets Investment Management LLC now owns 7,139 shares of the company’s stock worth $164,000 after acquiring an additional 6,886 shares during the period. Finally, Allspring Global Investments Holdings LLC grew its position in Privia Health Group by 30.7% in the fourth quarter. Allspring Global Investments Holdings LLC now owns 8,214 shares of the company’s stock valued at $189,000 after acquiring an additional 1,928 shares in the last quarter. 94.48% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of research analysts have recently commented on PRVA shares. Stifel Nicolaus reduced their target price on shares of Privia Health Group from $28.00 to $24.00 and set a “buy” rating on the stock in a research report on Wednesday, May 1st. Canaccord Genuity Group decreased their price objective on shares of Privia Health Group from $37.00 to $26.00 and set a “buy” rating for the company in a research report on Friday, May 10th. Truist Financial dropped their target price on Privia Health Group from $28.00 to $24.00 and set a “buy” rating on the stock in a research report on Wednesday, May 15th. Citigroup initiated coverage on Privia Health Group in a report on Monday, April 22nd. They issued a “buy” rating and a $25.00 price target for the company. Finally, Baird R W upgraded Privia Health Group to a “strong-buy” rating in a report on Thursday, May 30th. Two research analysts have rated the stock with a hold rating, eleven have given a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $24.54.

View Our Latest Report on PRVA

Privia Health Group Trading Up 0.1 %

PRVA stock opened at $17.08 on Wednesday. The stock’s 50 day simple moving average is $17.32 and its 200 day simple moving average is $19.45. Privia Health Group, Inc. has a 12-month low of $15.92 and a 12-month high of $28.23. The firm has a market cap of $2.04 billion, a P/E ratio of 113.87, a P/E/G ratio of 2.68 and a beta of 0.78.

Privia Health Group (NASDAQ:PRVAGet Free Report) last issued its earnings results on Thursday, May 9th. The company reported $0.02 earnings per share for the quarter, missing analysts’ consensus estimates of $0.05 by ($0.03). Privia Health Group had a return on equity of 3.13% and a net margin of 1.11%. The business had revenue of $415.24 million for the quarter, compared to analyst estimates of $435.07 million. On average, research analysts forecast that Privia Health Group, Inc. will post 0.2 EPS for the current fiscal year.

Insiders Place Their Bets

In related news, Director Adam Boehler bought 277,565 shares of the stock in a transaction dated Tuesday, May 21st. The stock was bought at an average cost of $16.17 per share, with a total value of $4,488,226.05. Following the completion of the acquisition, the director now owns 5,488,701 shares of the company’s stock, valued at $88,752,295.17. The purchase was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. In related news, Director Adam Boehler bought 277,565 shares of the business’s stock in a transaction on Tuesday, May 21st. The shares were bought at an average cost of $16.17 per share, for a total transaction of $4,488,226.05. Following the completion of the purchase, the director now owns 5,488,701 shares of the company’s stock, valued at approximately $88,752,295.17. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Thomas A. Mccarthy purchased 10,000 shares of the stock in a transaction dated Thursday, May 23rd. The shares were purchased at an average price of $16.37 per share, with a total value of $163,700.00. Following the transaction, the director now directly owns 52,611 shares of the company’s stock, valued at approximately $861,242.07. The disclosure for this purchase can be found here. Over the last quarter, insiders have acquired 293,235 shares of company stock valued at $4,745,481 and have sold 45,457 shares valued at $827,810. 14.20% of the stock is currently owned by corporate insiders.

Privia Health Group Company Profile

(Free Report)

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.

Read More

Want to see what other hedge funds are holding PRVA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Privia Health Group, Inc. (NASDAQ:PRVAFree Report).

Institutional Ownership by Quarter for Privia Health Group (NASDAQ:PRVA)

Receive News & Ratings for Privia Health Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Privia Health Group and related companies with MarketBeat.com's FREE daily email newsletter.